Cinvanti Prices, Coupons, Copay Cards & Patient Assistance
Cinvanti (aprepitant) is a member of the NK1 receptor antagonists drug class and is commonly used for Nausea/Vomiting, and Nausea/Vomiting - Chemotherapy Induced.
Cinvanti is available as a brand name drug only, a generic version is not yet available. View generic Cinvanti availability for more details.
Cinvanti prices
Intravenous Emulsion
130 mg/18 mL Cinvanti intravenous emulsion from $451.94 for 18 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 18 milliliters | $25.11 | $451.94 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Cinvanti Coupons, Copay Cards and Rebates
Cinvanti offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Cinvanti Heron Connect Copay Assistance Program
Eligible commercially insured patients who bring the enrollment form to their provider may pay $0 per dose per 12-month calendar period with a savings up to $200 per treatment.
- Applies to:
- Cinvanti
- Number of uses:
- per prescription per calendar year
Form more information phone: 844-437-6611 or Visit website
Cinvanti Heron Connect Copay Assistance Program
Eligible cash-paying patients may save $150 per dose; maximum savings of $1800 per calendar year; your healthcare provider must complete enrollment form.
- Applies to:
- Cinvanti
- Number of uses:
- per prescription per calendar year
Form more information phone: 844-437-6611 or Visit website
Patient Assistance & Copay Programs for Cinvanti
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Cinvanti (aprepitant) Injectable Emulsion for Intravenous use
More information please phone: 866-316-7263 Visit website
Provider: Heron Connect
Eligibility requirements:- Contact program for details.
- Determined case by case
- FDA-approved diagnosis
- Must be residing in the US or US territory
- Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
- Cinvanti (aprepitant) Injectable Emulsion for Intravenous use
More information please phone: 844-437-6611 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
More about Cinvanti (aprepitant)
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: NK1 receptor antagonists
- Breastfeeding
- En español